Skip to main content
Caplight Logo









KOA Biotech

KOA Biotech

Private
BarcelonaFrontier & Industrial Techhttps://koabiotech.com/

Last Round

Seed

Feb 6, 2025

Total Funding Raised

$2.08M

Company Overview

KOA Biotech is a biotechnology company that provides digital, autonomous, and onsite microbiological testing technology intended to reduce fish mortality from pathogenic infections.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Environmental Monitoring, Sensors, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

aquaculturebiosensorpathogen detectionsensing as a serviceagtechwater quality monitoringfish farmingearly warning systemprecision aquaculturebiotech hardwarepredictive diagnosticsmachine learningvertical SaaSautomated diagnosticssmart farming

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KOA Biotech Comparables

Compare KOA Biotech with similar companies based on industry and business-model similarity.

KOA Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kytos
81%
AQVA.AI
78%
MSortia LLP
77%

KOA Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 6, 2025

Key People

Founding team and executive leadership

Jordi Jubany Puigpinós

Chief Technology Officer

Executive Team

Greta Cánovas

CFO

Executive Team

KOA Biotech Investors

Notable investors and investment history

KOA Biotech investors
InvestorRounds
Swanlaab Venture FactorySeed
Pompeu Fabra UniversitySeed
Faber VenturesSeed
Fund FSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 533% MoM.

  • Feb 7, 2025

    Secured funding for autonomous biosensor system development.

Recent news

Latest coverage and updates

  • is_developingSep 3, 2026

    KOA Biotech is developing biosensor-based platform generation on Sep 3rd '26.

KOA Biotech Filings

Explore SEC and related filing metadata, where available.

KOA Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KOA Biotech's valuation, stock price, and market status.

Is KOA Biotech a public or private company?

KOA Biotech is a private company.

What is the current stock price of KOA Biotech?

KOA Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is KOA Biotech worth (valuation)?

Valuation information for KOA Biotech is not publicly available.

Can I buy KOA Biotech stock?

KOA Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KOA Biotech's last funding round?

KOA Biotech's most recent funding round was Early Funding on February 6, 2025.

Who are the main investors in KOA Biotech?

Key investors in KOA Biotech include Swanlaab Venture Factory.

Will KOA Biotech IPO soon?

No public IPO plans have been announced for KOA Biotech.

How can I track KOA Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KOA Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range15
Year Founded2021
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?